These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23567101)

  • 1. Defining a service for people who use drugs as 'low-threshold': what should be the criteria?
    Mofizul Islam M; Topp L; Conigrave KM; Day CA
    Int J Drug Policy; 2013 May; 24(3):220-2. PubMed ID: 23567101
    [No Abstract]   [Full Text] [Related]  

  • 2. Thresholds in a low-threshold setting: an empirical study of barriers in a centre for people with drug problems and mental health disorders.
    Edland-Gryt M; Skatvedt AH
    Int J Drug Policy; 2013 May; 24(3):257-64. PubMed ID: 23036653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance use 2: nursing assessment, management and types of intervention.
    Hamilton I
    Nurs Times; 2009 Jul 14-20; 105(27):14-7. PubMed ID: 19736828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inpatient staff perceptions in providing care to individuals with co-occurring mental health problems and illicit substance use.
    Howard V; Holmshaw J
    J Psychiatr Ment Health Nurs; 2010 Dec; 17(10):862-72. PubMed ID: 21078001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practices for the treatment of patients with mental and substance use illnesses in the emergency department.
    Slade M; Taber D; Clarke MM; Johnson C; Kapoor D; Leikin JB; Naylor M; Neal DA; Novak J; Steiner D; Temkin T; Teodo P; Tippy A; Tronc V; Yohanna D; Zehr E; Zun L;
    Dis Mon; 2007; 53(11-12):536-80. PubMed ID: 18068802
    [No Abstract]   [Full Text] [Related]  

  • 6. The 'co-morbidity roundabout': a framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems.
    Kay-Lambkin FJ; Baker AL; Lewin TJ
    Drug Alcohol Rev; 2004 Dec; 23(4):407-23. PubMed ID: 15763746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of people with co-existing psychiatric and substance use disorders: patterns of use and outcomes.
    Greig RL; Baker A; Lewin TJ; Webster RA; Carr VJ
    Drug Alcohol Rev; 2006 May; 25(3):249-58. PubMed ID: 16753649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motives for substance use among young people seeking mental health treatment.
    Hides L; Lubman DI; Cosgrave EM; Buckby JA; Killackey E; Yung AR
    Early Interv Psychiatry; 2008 Aug; 2(3):188-94. PubMed ID: 21352152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving health and social care relationships for harm reduction.
    Allman D; Myers T; Schellenberg J; Strike C; Cockerill R; Cavalieri W
    Int J Drug Policy; 2007 May; 18(3):194-203. PubMed ID: 17689366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missing the continuum.
    Sobell MB; Sobell LC
    Addiction; 2010 Jan; 105(1):17-8. PubMed ID: 20078457
    [No Abstract]   [Full Text] [Related]  

  • 13. Emotion regulation promotes persistence in a residential substance abuse treatment.
    Hopwood CJ; Schade N; Matusiewicz A; Daughters SB; Lejuez CW
    Subst Use Misuse; 2015 Jan; 50(2):251-6. PubMed ID: 25404467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of treatment in a population of adolescents with alcohol use disorders.
    Bukstein OG; Cornelius J; Trunzo AC; Kelly TM; Wood DS
    Addict Behav; 2005 Oct; 30(9):1663-73. PubMed ID: 16165305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulant use disorders: characteristics and comorbidity in an Australian population sample.
    Sara G; Burgess P; Harris M; Malhi GS; Whiteford H; Hall W
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1173-81. PubMed ID: 22990432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to alcohol, drugs and tobacco and the risk of subsequent suicidality: findings from the Mexican Adolescent Mental Health Survey.
    Miller M; Borges G; Orozco R; Mukamal K; Rimm EB; Benjet C; Medina-Mora ME
    Drug Alcohol Depend; 2011 Jan; 113(2-3):110-7. PubMed ID: 20801585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nursing considerations for dual diagnosis in mental health.
    Edward KL; Munro I
    Int J Nurs Pract; 2009 Apr; 15(2):74-9. PubMed ID: 19335524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A folk model of treatment readiness among drug users in Ohio.
    Redko C; Carlson RG; Rapp RC
    J Ethn Subst Abuse; 2007; 6(2):15-40. PubMed ID: 18192202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Towards a global approach'--an overview of Harm Reduction 2008: IHRA's 19th International Conference.
    Fraser S; Hopwood M; Madden A; Treloar C
    Int J Drug Policy; 2009 Jan; 20(1):93-7. PubMed ID: 18835148
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding How People with Mental Health Difficulties Experience Substance Use.
    Chorlton E; Smith IC
    Subst Use Misuse; 2016; 51(3):318-29. PubMed ID: 26894310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.